SCHEMBL6366348

SCHEMBL6366348

Cc1cccc(C(=O)Oc2cccc3c2C(=O)c2cccc(OC(=O)c4cccc(C)c4)c2C3=O)c1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 6/20 0.58
POLB P06746 3/20 0.58
MEN1 O00255 2/20 0.58
ESR1 P03372 2/20 0.58
ESR2 Q92731 1/20 0.58
MAPT P10636 6/20 0.50
KDM4E B2RXH2 3/20 0.50
TTR P02766 2/20 0.50
TOP1 P11387 1/20 0.50
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
GAA P10253 1/20 0.49
CYP2C9 P11712 1/20 0.49
CYP2C19 P33261 1/20 0.49
MAPK1 P28482 2/20 0.48
ALDH1A1 P00352 2/20 0.48
TP53 P04637 2/20 0.48
ABCC4 O15439 1/20 0.48
USP2 O75604 1/20 0.48
LMNA P02545 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27584375 0.96 KMT2A (0.55) KMT2APOLBMEN1ESR1ESR2
SCHEMBL6367150 0.85 ESR1 (0.56) KMT2APOLBMEN1ESR1ESR2
SCHEMBL6367155 0.83 TOP1 (0.69) KMT2AMEN1ESR1ESR2MAPT
SCHEMBL27584326 0.81 S100A4 (0.57) KMT2APOLBMEN1ESR1ESR2
SCHEMBL11524597 0.80 TOP1 (0.66) KMT2AMEN1ESR1ESR2MAPT
SCHEMBL19509565 0.79 KMT2A (0.70) KMT2APOLBMEN1ESR1ESR2
SCHEMBL15851050 0.78 KMT2A (0.64) KMT2APOLBMEN1ESR1ESR2
SCHEMBL13964390 0.77 KMT2A (0.59) KMT2APOLBMEN1ESR1ESR2
SCHEMBL20646411 0.77 KMT2A (0.62) KMT2APOLBMEN1ESR1ESR2
SCHEMBL11529372 0.76 EGFR (0.57) KMT2APOLBMEN1ESR1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives HUANG HSU-SHAN (TW) 2005-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050009924-A1 Synthesis and pharmaceuticals of novel bis-substituted anthraquinone derivatives NFE2L2, NR2F2, TFAM KMT2A 1696/4885POLB 446/4885MEN1 4402/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.